Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Terminated
79 enrolled 24 charts
PROACT
Phase 2 Terminated
49 enrolled 12 charts
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Phase 2 Terminated
54 enrolled 11 charts
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
Phase NA Terminated
24 enrolled
LODESTAR
Phase 2 Terminated
83 enrolled 16 charts
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
Phase 1/2 Terminated
3 enrolled 10 charts
ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
Phase NA Terminated
37 enrolled 10 charts
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Phase 1 Terminated
10 enrolled
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
Phase 1 Terminated
19 enrolled
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
Phase 1 Terminated
39 enrolled
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
Phase NA Terminated
39 enrolled
N1
Terminated
23 enrolled
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Phase 1 Terminated
31 enrolled 12 charts
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Phase 1 Terminated
24 enrolled 10 charts
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Phase 1 Terminated
38 enrolled
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
Phase 2/3 Terminated
54 enrolled